Mabura 40 mg Pen is a medicine used to treat a variety of conditions including ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis and Crohn's disease. Mabura 40 mg is a disease-modifying anti-rheumatic drug and a monoclonal antibody that works by inactivating tumour necrosis factor-alpha (TNFα). It helps reduce the swelling, pain and redness associated with several conditions and improves physical function. It is administered by injection under the skin.
Common side effects include headache, sinusitis, rash, upper respiratory infection, and injection site reactions such as pain, redness, and swelling. If you experience any of these side effects, you should talk to your doctor if they do not get better over time or if they get worse. Your doctor or health care professional may be able to give you advice on the reduction or prevention of these symptoms.
Before taking Mabura 40 mg Pen, tell your doctor if you have heart, kidney or liver problems, or if you have infections such as tuberculosis (TB) or other bacterial, fungal or viral infections. If you have a nervous system disorder, including multiple sclerosis, optic neuritis, or Guillain-Barre syndrome. All other medicines you are taking should also be told to your doctor. Women who are pregnant or breastfeeding should seek the advice of their doctor or health professional before taking this medicine.
Mabura 40 mg is given by a health care professional and should not be used by yourself. You should take it regularly at the same time each day to get maximum benefit. Take your medicine as directed by your doctor. Finish the full course of medicine even if you feel better.
Rheumatoid arthritis: Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. It causes inflammation, pain, stiffness, and swelling in the joints, and can also affect other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. Mabura 40 mg helps reduce inflammation and manage the symptoms of Rheumatoid arthritis.
Ankylosing spondylitis: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and reduced mobility. It is a form of arthritis that mainly affects the joints between the vertebrae in the spine and the sacroiliac joints where the spine connects to the pelvis. Mabura 40 Pen works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing the inflammation associated with ankylosing spondylitis, Mabura 40 mg Pen can help relieve pain, stiffness, and other symptoms of the condition.
Crohn's disease: Crohn's disease is a chronic inflammatory bowel disease (IBD) that primarily affects the gastrointestinal tract. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Symptoms of Crohn's disease can vary but commonly include abdominal pain, diarrhoea, weight loss, fatigue, and loss of appetite. Mabura 40 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the gastrointestinal tract, Mabura 40 mg Pen can help manage the symptoms of Crohn's disease, including abdominal pain, diarrhoea, and inflammation.
Ulcerative colitis: Ulcerative colitis is a chronic inflammatory bowel disease that primarily affects the colon and rectum. Mabura 40 Pen can help reduce inflammation in the gastrointestinal tract and manage the symptoms of ulcerative colitis.
Hidradenitis suppurativa: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects the hair follicles in areas of the body with a high concentration of sweat glands, such as the armpits, groin, and buttocks. Mabura 40 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation, Mabura 40 mg Pen can help alleviate symptoms and prevent the progression of hidradenitis suppurativa.
Juvenile idiopathic arthritis: Juvenile idiopathic arthritis (JIA) is a type of arthritis that occurs in children under the age of 16 and persists for at least six weeks. It is characterized by joint inflammation, pain, stiffness, and swelling. Mabura 40 mg Pen works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab helps manage the symptoms of Juvenile idiopathic arthritis, including pain, stiffness, and swelling.
Plaque psoriasis: Psoriasis is a condition where the skin cells in the body grow too quickly and form scales and dry patches. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back. Mabura 40 Pen reduces the scaly, itchy patches which may develop on the different parts of the body. It may take several months to become fully effective. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Psoriatic arthritis: Psoriatic arthritis is a type of inflammatory arthritis that occurs in some individuals with psoriasis, a chronic skin condition. It causes joint pain, swelling, and stiffness, and can affect any joint in the body. Mabura 40 mg Pen works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab can help manage the symptoms of psoriatic arthritis, including joint pain, stiffness, and swelling.
Uveitis: Uveitis refers to the inflammation of the uvea, which is the middle layer of the eye. It can affect various parts of the uvea, including the iris, ciliary body, and choroid. Mabura 40 mg is a tumour necrosis factor (TNF) inhibitor that helps reduce inflammation by targeting TNF, a protein involved in the immune response.
Mabura 40 mg Pen is given subcutaneously (under the skin) from any health care professional. Dosage and frequency will be decided by your doctor as per your disease condition and several other factors.
Mabura 40 mg Pen is a disease-modifying antirheumatic drug and a monoclonal antibody. Mabura 40 mg blocks the action of certain chemical messengers that are responsible for inflammation, swelling and redness associated with certain joint diseases.
Mabura 40 mg is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
patients with kidney disease should closely monitor kidney function while taking Mabura 40 mg Pen and report any unusual symptoms or changes in kidney function to their physician. The dose of Mabura 40 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
Mabura 40 Pen is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects on the developing baby; however, there are limited human studies.
Mabura 40 mg Pen may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Mabura 40 mg.
It is generally not recommended to drink alcohol while taking Mabura 40. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Mabura 40 mg Pen should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Mabura 40 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Mabura 40 may need to be adjusted in patients with liver disease.
1. Adalimumab, Medscape.Com, Avaliable Form
2. Adalimumab, Drugs.Com, Avaliable Form
3. Humira, (Adalimumab) Injection, for Subcutaneous Use, Abbvie Inc, Product Leaflet
4. Adalimumab, National Health Service (Nhs), Avaliable Form